Lavipharm S.A Free Cash Flow Generation Index

Latest as of December 2022: 34.32x

Lavipharm S.A free cash flow generation index. Lavipharm S.A (LAVI) has a Free Cash Flow Generation Index of 34.32x as of December 2022. Free cash flow of €18.09 Million represents 34% of operating cash flow (€527.00K). Check Lavipharm S.A asset resilience ratio to evaluate the company's liquid asset resilience ratio.

FCF Generation Index

34.32x
Free Cash Flow / Operating CF

Free Cash Flow

€18.09 Million
EUR

Operating Cash Flow

€527.00K
EUR

Capital Expenditures

€17.56 Million
EUR

Free Cash Flow Generation Index of Lavipharm S.A (2014–2024)

Free cash flow generation index of Lavipharm S.A from 2014 to 2024. Historical FCF Generation Index trend for Lavipharm S.A across 11 annual periods. Explore Lavipharm S.A capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Lavipharm S.A Free Cash Flow Generation Index by Year (2014–2024)

Lavipharm S.A free cash flow generation index by year from 2014 to 2024. Year-by-year Free Cash Flow Generation Index for Lavipharm S.A. For the full cash flow conversion analysis, see cash efficiency ratio of Lavipharm S.A.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2024 -1.08x €-5.00 Million €4.64 Million €9.64 Million ▲ +91.9%
2023 -13.26x €-3.77 Million €284.00K €4.05 Million ▼ -37.5%
2022 -9.64x €-32.27 Million €3.35 Million €35.62 Million ▼ -1779.8%
2021 0.57x €2.19 Million €3.82 Million €1.92 Million ▲ +19.1%
2020 0.48x €1.37 Million €2.85 Million €1.48 Million ▼ -73.7%
2019 1.84x €5.31 Million €2.89 Million €2.42 Million ▲ +6.2%
2018 1.73x €2.45 Million €1.42 Million €1.03 Million ▲ +40.4%
2017 1.23x €1.86 Million €1.51 Million €350.00K ▲ +6.1%
2016 1.16x €703.00K €606.00K €97.00K ▲ +11.6%
2015 1.04x €599.00K €576.00K €23.00K ▼ -30.9%
2014 1.51x €3.58 Million €2.38 Million €1.20 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).